You may remember that I was in a clinical trial using Selenium with Carboplatin and Taxol for treatment of ovarian cancer.
Research into selenium and various cancers continues at CINJ. I received this e-mail about a clinical trial at CINJ that will study selenium to reduce the risk of prostate in men.
Healthy male volunteers needed
Researchers at The Cancer Institute of New Jersey (CINJ) are studying the role of the mineral selenium in reducing one's risk for prostate cancer. Consider taking part in this study...and join the team!
CINJ researchers are trying to see if selenium yeast or selenomethionine lower
prostate-specific antigen (PSA) levels and prevent other markers related to the
development of prostate cancer in healthy men of different age groups.
Participants will be asked to take over-the-counter selenium supplements or a placebo
for twelve months.Five visits to CINJ are required during the study, where blood and urine samples will
be taken.
Compensation is provided.
You may be eligible to participate if you:
Are a healthy male between 20 and 79 years
of age
Have no evidence of prostate cancer
Are a nonsmoker
Can visit CINJ five times over twelve months.
To see if you are eligible for this study,
contact Michelle Orlick at 732-235-6048 or
orlickmi@umdnj.edu.
Dee
Every day is a Blessing!
Showing posts with label Prostate Cancer. Show all posts
Showing posts with label Prostate Cancer. Show all posts
Monday, August 15, 2011
Wednesday, March 5, 2008
DeLauro - King Dear Colleague Letter
Believe it or not the Department of Defense (DoD) has Medical Research Programs.
Now is the time for the House Appropriations Subcommittee to support an increase in funding for the Ovarian and Prostate Cancer Research Programs (CDMRP) for the fiscal year 2009. Two members of the House - De Lauro and King have asked their colleagues to sign a letter to support an increase in funding for the programs.
As you may know there is no early detection test for ovarian cancer, so most women are diagnosed in late stage when survival rates are decreased. One in 69 women will develop Ovarian Cancer.
More than 218,000 prostate cancer cases are diagnosed each year and more than 27,000 will losetheir life to the disease.
The letter requests the subcommittee allocate $25 million for (OCRP) the Ovarian Cancer Research program and $100 million for the Prostate program.
Please write or call your representative . You can send him/her an e-mail through this Ovarian Cancer National Alliance site.
Now is the time for the House Appropriations Subcommittee to support an increase in funding for the Ovarian and Prostate Cancer Research Programs (CDMRP) for the fiscal year 2009. Two members of the House - De Lauro and King have asked their colleagues to sign a letter to support an increase in funding for the programs.
As you may know there is no early detection test for ovarian cancer, so most women are diagnosed in late stage when survival rates are decreased. One in 69 women will develop Ovarian Cancer.
More than 218,000 prostate cancer cases are diagnosed each year and more than 27,000 will losetheir life to the disease.
The letter requests the subcommittee allocate $25 million for (OCRP) the Ovarian Cancer Research program and $100 million for the Prostate program.
Please write or call your representative . You can send him/her an e-mail through this Ovarian Cancer National Alliance site.
Subscribe to:
Posts (Atom)